Provided by Tiger Fintech (Singapore) Pte. Ltd.

Voyager Therapeutics

3.64
+0.09002.54%
Post-market: 3.57-0.0700-1.92%19:01 EDT
Volume:296.67K
Turnover:1.08M
Market Cap:200.95M
PE:-3.22
High:3.69
Open:3.57
Low:3.56
Close:3.55
Loading ...

Cantor Fitzgerald Initiates Voyager Therapeutics at Overweight

MT Newswires Live
·
10 Jan

Should Weakness in Voyager Therapeutics, Inc.'s (NASDAQ:VYGR) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Simply Wall St.
·
24 Dec 2024

3 Biotech Stocks With Promising Gene Therapies to Watch Out in 2025

Zacks
·
17 Dec 2024

Voyager Therapeutics Shares up 4.5% After Citigroup Starts Coverage With 'Buy'

THOMSON REUTERS
·
02 Dec 2024

BUZZ-Voyager Therapeutics rises after Citigroup starts coverage with 'buy'

Reuters
·
02 Dec 2024

Voyager Therapeutics Shares up 1.3% Premarket After Citigroup Initiates With Buy Rating

THOMSON REUTERS
·
02 Dec 2024

BUZZ-Voyager Therapeutics rises after Wedbush starts with 'outperform'

Reuters
·
29 Nov 2024

Voyager Therapeutics Shares up 6.9% Premarket After Wedbush Assumes Coverage With Outperform Rating

THOMSON REUTERS
·
29 Nov 2024

Wedbush Upgrades Voyager Therapeutics to Outperform From Neutral, Raises Price Target to $11 From $7

MT Newswires Live
·
29 Nov 2024

Wedbush upgrades Voyager to Outperform on pipeline progress

TIPRANKS
·
29 Nov 2024

Voyager Therapeutics assumed with Outperform from Neutral at Wedbush

TIPRANKS
·
29 Nov 2024

Voyager Therapeutics Inc : Wedbush Assumes Coverage With Outperform VS Neutral Rating; Target Price $11 VS $7

THOMSON REUTERS
·
29 Nov 2024

Voyager Therapeutics Selects Development Candidate for Tau Silencing Program in Alzheimer's Disease

MT Newswires Live
·
20 Nov 2024

Voyager selects gene therapy development candidate for Alzheimer’s disease

seekingalpha
·
20 Nov 2024

BRIEF-Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease

Reuters
·
20 Nov 2024

Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease

THOMSON REUTERS
·
20 Nov 2024

Voyager Therapeutics : Candidate Vy1706 Demonstrates Significant Reductions of Tau at Low Doses in Nhp Study; Ind & Cta Filings Anticipated in 2026

THOMSON REUTERS
·
20 Nov 2024

Voyager Therapeutics Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
15 Nov 2024

Analysts Are Bullish on Top Healthcare Stocks: Voyager Therapeutics (VYGR), BioNTech SE (BNTX)

TIPRANKS
·
14 Nov 2024

Declining Stock and Decent Financials: Is The Market Wrong About Voyager Therapeutics, Inc. (NASDAQ:VYGR)?

Simply Wall St.
·
14 Nov 2024